Tumor specimens were classified as low or high methylation (see Materials and methods for details on quantification and classification of promoter methylation), divided into two groups and compared with the mRNA expression levels of FBXW7/hCDC4-β. This evidence concerns the gene FBXW7 and neoplasm.